Global Siponimod Market Research Report 2023
Siponimod, sold under the brand name Mayzent, is a selective sphingosine-1-phosphate receptor modulator for oral use that is used for multiple sclerosis (MS). It is intended for once-daily oral administration.
According to QYResearch’s new survey, global Siponimod market is projected to reach US$ 967.9 million in 2029, increasing from US$ 357 million in 2022, with the CAGR of 13.2% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Siponimod market research.
The Siponimod market is primarily driven by the increasing demand for effective treatments for multiple sclerosis (MS), specifically for secondary progressive forms of the disease. Siponimod is an oral medication that modulates sphingosine 1-phosphate receptors, aiming to slow down the progression of disability in MS patients. The growing prevalence of MS and the need for therapies that address the more advanced stages of the disease contribute to market growth. Moreover, the convenience of oral administration compared to injectable treatments and the potential for improved patient quality of life further propel adoption. However, challenges include potential side effects and the need for close monitoring of patients, particularly during the treatment initiation phase. Navigating regulatory requirements and competition in the MS treatment landscape, alongside addressing affordability and access barriers for a broader patient population, pose ongoing concerns. The market's success relies on continuous research to optimize dosing regimens, comprehensive patient education about potential benefits and risks, and collaborations between pharmaceutical companies, healthcare providers, and MS patient organizations to advance MS management while addressing the evolving challenges associated with Siponimod therapy.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Siponimod market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
According to QYResearch’s new survey, global Siponimod market is projected to reach US$ 967.9 million in 2029, increasing from US$ 357 million in 2022, with the CAGR of 13.2% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Siponimod market research.
The Siponimod market is primarily driven by the increasing demand for effective treatments for multiple sclerosis (MS), specifically for secondary progressive forms of the disease. Siponimod is an oral medication that modulates sphingosine 1-phosphate receptors, aiming to slow down the progression of disability in MS patients. The growing prevalence of MS and the need for therapies that address the more advanced stages of the disease contribute to market growth. Moreover, the convenience of oral administration compared to injectable treatments and the potential for improved patient quality of life further propel adoption. However, challenges include potential side effects and the need for close monitoring of patients, particularly during the treatment initiation phase. Navigating regulatory requirements and competition in the MS treatment landscape, alongside addressing affordability and access barriers for a broader patient population, pose ongoing concerns. The market's success relies on continuous research to optimize dosing regimens, comprehensive patient education about potential benefits and risks, and collaborations between pharmaceutical companies, healthcare providers, and MS patient organizations to advance MS management while addressing the evolving challenges associated with Siponimod therapy.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Siponimod market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
- Novartis
- 0.25mg
- 0.2mg
- Retail Pharmacy
- Hospital Pharmacy
- Other
- North America
- United States
- Canada
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Australia
- China Taiwan
- Indonesia
- Thailand
- Malaysia
- Latin America
- Mexico
- Brazil
- Argentina
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
1 SIPONIMOD MARKET OVERVIEW
1.1 Product Overview and Scope of Siponimod
1.2 Siponimod Segment by Type
1.2.1 Global Siponimod Market Value Comparison by Type (2023-2029)
1.2.2 0.25mg
1.2.3 0.2mg
1.3 Siponimod Segment by Application
1.3.1 Global Siponimod Market Value by Application: (2023-2029)
1.3.2 Retail Pharmacy
1.3.3 Hospital Pharmacy
1.3.4 Other
1.4 Global Siponimod Market Size Estimates and Forecasts
1.4.1 Global Siponimod Revenue 2018-2029
1.4.2 Global Siponimod Sales 2018-2029
1.4.3 Global Siponimod Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 SIPONIMOD MARKET COMPETITION BY MANUFACTURERS
2.1 Global Siponimod Sales Market Share by Manufacturers (2018-2023)
2.2 Global Siponimod Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Siponimod Average Price by Manufacturers (2018-2023)
2.4 Global Siponimod Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Siponimod, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Siponimod, Product Type & Application
2.7 Siponimod Market Competitive Situation and Trends
2.7.1 Siponimod Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Siponimod Players Market Share by Revenue
2.7.3 Global Siponimod Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 SIPONIMOD RETROSPECTIVE MARKET SCENARIO BY REGION
3.1 Global Siponimod Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Siponimod Global Siponimod Sales by Region: 2018-2029
3.2.1 Global Siponimod Sales by Region: 2018-2023
3.2.2 Global Siponimod Sales by Region: 2024-2029
3.3 Global Siponimod Global Siponimod Revenue by Region: 2018-2029
3.3.1 Global Siponimod Revenue by Region: 2018-2023
3.3.2 Global Siponimod Revenue by Region: 2024-2029
3.4 North America Siponimod Market Facts & Figures by Country
3.4.1 North America Siponimod Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Siponimod Sales by Country (2018-2029)
3.4.3 North America Siponimod Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Siponimod Market Facts & Figures by Country
3.5.1 Europe Siponimod Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Siponimod Sales by Country (2018-2029)
3.5.3 Europe Siponimod Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Siponimod Market Facts & Figures by Country
3.6.1 Asia Pacific Siponimod Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Siponimod Sales by Country (2018-2029)
3.6.3 Asia Pacific Siponimod Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Siponimod Market Facts & Figures by Country
3.7.1 Latin America Siponimod Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Siponimod Sales by Country (2018-2029)
3.7.3 Latin America Siponimod Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Siponimod Market Facts & Figures by Country
3.8.1 Middle East and Africa Siponimod Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Siponimod Sales by Country (2018-2029)
3.8.3 Middle East and Africa Siponimod Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 SEGMENT BY TYPE
4.1 Global Siponimod Sales by Type (2018-2029)
4.1.1 Global Siponimod Sales by Type (2018-2023)
4.1.2 Global Siponimod Sales by Type (2024-2029)
4.1.3 Global Siponimod Sales Market Share by Type (2018-2029)
4.2 Global Siponimod Revenue by Type (2018-2029)
4.2.1 Global Siponimod Revenue by Type (2018-2023)
4.2.2 Global Siponimod Revenue by Type (2024-2029)
4.2.3 Global Siponimod Revenue Market Share by Type (2018-2029)
4.3 Global Siponimod Price by Type (2018-2029)
5 SEGMENT BY APPLICATION
5.1 Global Siponimod Sales by Application (2018-2029)
5.1.1 Global Siponimod Sales by Application (2018-2023)
5.1.2 Global Siponimod Sales by Application (2024-2029)
5.1.3 Global Siponimod Sales Market Share by Application (2018-2029)
5.2 Global Siponimod Revenue by Application (2018-2029)
5.2.1 Global Siponimod Revenue by Application (2018-2023)
5.2.2 Global Siponimod Revenue by Application (2024-2029)
5.2.3 Global Siponimod Revenue Market Share by Application (2018-2029)
5.3 Global Siponimod Price by Application (2018-2029)
6 KEY COMPANIES PROFILED
6.1 Novartis
6.1.1 Novartis Corporation Information
6.1.2 Novartis Description and Business Overview
6.1.3 Novartis Siponimod Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Novartis Siponimod Product Portfolio
6.1.5 Novartis Recent Developments/Updates
7 INDUSTRY CHAIN AND SALES CHANNELS ANALYSIS
7.1 Siponimod Industry Chain Analysis
7.2 Siponimod Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Siponimod Production Mode & Process
7.4 Siponimod Sales and Marketing
7.4.1 Siponimod Sales Channels
7.4.2 Siponimod Distributors
7.5 Siponimod Customers
8 SIPONIMOD MARKET DYNAMICS
8.1 Siponimod Industry Trends
8.2 Siponimod Market Drivers
8.3 Siponimod Market Challenges
8.4 Siponimod Market Restraints
9 RESEARCH FINDING AND CONCLUSION
10 METHODOLOGY AND DATA SOURCE
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
1.1 Product Overview and Scope of Siponimod
1.2 Siponimod Segment by Type
1.2.1 Global Siponimod Market Value Comparison by Type (2023-2029)
1.2.2 0.25mg
1.2.3 0.2mg
1.3 Siponimod Segment by Application
1.3.1 Global Siponimod Market Value by Application: (2023-2029)
1.3.2 Retail Pharmacy
1.3.3 Hospital Pharmacy
1.3.4 Other
1.4 Global Siponimod Market Size Estimates and Forecasts
1.4.1 Global Siponimod Revenue 2018-2029
1.4.2 Global Siponimod Sales 2018-2029
1.4.3 Global Siponimod Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 SIPONIMOD MARKET COMPETITION BY MANUFACTURERS
2.1 Global Siponimod Sales Market Share by Manufacturers (2018-2023)
2.2 Global Siponimod Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Siponimod Average Price by Manufacturers (2018-2023)
2.4 Global Siponimod Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Siponimod, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Siponimod, Product Type & Application
2.7 Siponimod Market Competitive Situation and Trends
2.7.1 Siponimod Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Siponimod Players Market Share by Revenue
2.7.3 Global Siponimod Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 SIPONIMOD RETROSPECTIVE MARKET SCENARIO BY REGION
3.1 Global Siponimod Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Siponimod Global Siponimod Sales by Region: 2018-2029
3.2.1 Global Siponimod Sales by Region: 2018-2023
3.2.2 Global Siponimod Sales by Region: 2024-2029
3.3 Global Siponimod Global Siponimod Revenue by Region: 2018-2029
3.3.1 Global Siponimod Revenue by Region: 2018-2023
3.3.2 Global Siponimod Revenue by Region: 2024-2029
3.4 North America Siponimod Market Facts & Figures by Country
3.4.1 North America Siponimod Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Siponimod Sales by Country (2018-2029)
3.4.3 North America Siponimod Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Siponimod Market Facts & Figures by Country
3.5.1 Europe Siponimod Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Siponimod Sales by Country (2018-2029)
3.5.3 Europe Siponimod Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Siponimod Market Facts & Figures by Country
3.6.1 Asia Pacific Siponimod Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Siponimod Sales by Country (2018-2029)
3.6.3 Asia Pacific Siponimod Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Siponimod Market Facts & Figures by Country
3.7.1 Latin America Siponimod Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Siponimod Sales by Country (2018-2029)
3.7.3 Latin America Siponimod Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Siponimod Market Facts & Figures by Country
3.8.1 Middle East and Africa Siponimod Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Siponimod Sales by Country (2018-2029)
3.8.3 Middle East and Africa Siponimod Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 SEGMENT BY TYPE
4.1 Global Siponimod Sales by Type (2018-2029)
4.1.1 Global Siponimod Sales by Type (2018-2023)
4.1.2 Global Siponimod Sales by Type (2024-2029)
4.1.3 Global Siponimod Sales Market Share by Type (2018-2029)
4.2 Global Siponimod Revenue by Type (2018-2029)
4.2.1 Global Siponimod Revenue by Type (2018-2023)
4.2.2 Global Siponimod Revenue by Type (2024-2029)
4.2.3 Global Siponimod Revenue Market Share by Type (2018-2029)
4.3 Global Siponimod Price by Type (2018-2029)
5 SEGMENT BY APPLICATION
5.1 Global Siponimod Sales by Application (2018-2029)
5.1.1 Global Siponimod Sales by Application (2018-2023)
5.1.2 Global Siponimod Sales by Application (2024-2029)
5.1.3 Global Siponimod Sales Market Share by Application (2018-2029)
5.2 Global Siponimod Revenue by Application (2018-2029)
5.2.1 Global Siponimod Revenue by Application (2018-2023)
5.2.2 Global Siponimod Revenue by Application (2024-2029)
5.2.3 Global Siponimod Revenue Market Share by Application (2018-2029)
5.3 Global Siponimod Price by Application (2018-2029)
6 KEY COMPANIES PROFILED
6.1 Novartis
6.1.1 Novartis Corporation Information
6.1.2 Novartis Description and Business Overview
6.1.3 Novartis Siponimod Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Novartis Siponimod Product Portfolio
6.1.5 Novartis Recent Developments/Updates
7 INDUSTRY CHAIN AND SALES CHANNELS ANALYSIS
7.1 Siponimod Industry Chain Analysis
7.2 Siponimod Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Siponimod Production Mode & Process
7.4 Siponimod Sales and Marketing
7.4.1 Siponimod Sales Channels
7.4.2 Siponimod Distributors
7.5 Siponimod Customers
8 SIPONIMOD MARKET DYNAMICS
8.1 Siponimod Industry Trends
8.2 Siponimod Market Drivers
8.3 Siponimod Market Challenges
8.4 Siponimod Market Restraints
9 RESEARCH FINDING AND CONCLUSION
10 METHODOLOGY AND DATA SOURCE
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
LIST OF TABLES
Table 1. Global Siponimod Market Value Comparison by Type (2023-2029) & (US$ Million)
Table 2. Global Siponimod Market Value Comparison by Application (2023-2029) & (US$ Million)
Table 3. Global Siponimod Market Competitive Situation by Manufacturers in 2022
Table 4. Global Siponimod Sales (K Units) of Key Manufacturers (2018-2023)
Table 5. Global Siponimod Sales Market Share by Manufacturers (2018-2023)
Table 6. Global Siponimod Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global Siponimod Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market Siponimod Average Price (US$/Unit) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of Siponimod, Industry Ranking, 2021 VS 2022 VS 2023
Table 10. Global Key Manufacturers of Siponimod, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Siponimod, Product Type & Application
Table 12. Global Key Manufacturers of Siponimod, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Siponimod by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Siponimod as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Siponimod Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Siponimod Sales by Region (2018-2023) & (K Units)
Table 18. Global Siponimod Sales Market Share by Region (2018-2023)
Table 19. Global Siponimod Sales by Region (2024-2029) & (K Units)
Table 20. Global Siponimod Sales Market Share by Region (2024-2029)
Table 21. Global Siponimod Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global Siponimod Revenue Market Share by Region (2018-2023)
Table 23. Global Siponimod Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Siponimod Revenue Market Share by Region (2024-2029)
Table 25. North America Siponimod Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Siponimod Sales by Country (2018-2023) & (K Units)
Table 27. North America Siponimod Sales by Country (2024-2029) & (K Units)
Table 28. North America Siponimod Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America Siponimod Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Siponimod Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Siponimod Sales by Country (2018-2023) & (K Units)
Table 32. Europe Siponimod Sales by Country (2024-2029) & (K Units)
Table 33. Europe Siponimod Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe Siponimod Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Siponimod Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Siponimod Sales by Region (2018-2023) & (K Units)
Table 37. Asia Pacific Siponimod Sales by Region (2024-2029) & (K Units)
Table 38. Asia Pacific Siponimod Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific Siponimod Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Siponimod Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Siponimod Sales by Country (2018-2023) & (K Units)
Table 42. Latin America Siponimod Sales by Country (2024-2029) & (K Units)
Table 43. Latin America Siponimod Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America Siponimod Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Siponimod Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Siponimod Sales by Country (2018-2023) & (K Units)
Table 47. Middle East & Africa Siponimod Sales by Country (2024-2029) & (K Units)
Table 48. Middle East & Africa Siponimod Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Siponimod Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Siponimod Sales (K Units) by Type (2018-2023)
Table 51. Global Siponimod Sales (K Units) by Type (2024-2029)
Table 52. Global Siponimod Sales Market Share by Type (2018-2023)
Table 53. Global Siponimod Sales Market Share by Type (2024-2029)
Table 54. Global Siponimod Revenue (US$ Million) by Type (2018-2023)
Table 55. Global Siponimod Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Siponimod Revenue Market Share by Type (2018-2023)
Table 57. Global Siponimod Revenue Market Share by Type (2024-2029)
Table 58. Global Siponimod Price (US$/Unit) by Type (2018-2023)
Table 59. Global Siponimod Price (US$/Unit) by Type (2024-2029)
Table 60. Global Siponimod Sales (K Units) by Application (2018-2023)
Table 61. Global Siponimod Sales (K Units) by Application (2024-2029)
Table 62. Global Siponimod Sales Market Share by Application (2018-2023)
Table 63. Global Siponimod Sales Market Share by Application (2024-2029)
Table 64. Global Siponimod Revenue (US$ Million) by Application (2018-2023)
Table 65. Global Siponimod Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Siponimod Revenue Market Share by Application (2018-2023)
Table 67. Global Siponimod Revenue Market Share by Application (2024-2029)
Table 68. Global Siponimod Price (US$/Unit) by Application (2018-2023)
Table 69. Global Siponimod Price (US$/Unit) by Application (2024-2029)
Table 70. Novartis Corporation Information
Table 71. Novartis Description and Business Overview
Table 72. Novartis Siponimod Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 73. Novartis Siponimod Product
Table 74. Novartis Recent Developments/Updates
Table 75. Key Raw Materials Lists
Table 76. Raw Materials Key Suppliers Lists
Table 77. Siponimod Distributors List
Table 78. Siponimod Customers List
Table 79. Siponimod Market Trends
Table 80. Siponimod Market Drivers
Table 81. Siponimod Market Challenges
Table 82. Siponimod Market Restraints
Table 83. Research Programs/Design for This Report
Table 84. Key Data Information from Secondary Sources
Table 85. Key Data Information from Primary Sources
Table 1. Global Siponimod Market Value Comparison by Type (2023-2029) & (US$ Million)
Table 2. Global Siponimod Market Value Comparison by Application (2023-2029) & (US$ Million)
Table 3. Global Siponimod Market Competitive Situation by Manufacturers in 2022
Table 4. Global Siponimod Sales (K Units) of Key Manufacturers (2018-2023)
Table 5. Global Siponimod Sales Market Share by Manufacturers (2018-2023)
Table 6. Global Siponimod Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global Siponimod Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market Siponimod Average Price (US$/Unit) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of Siponimod, Industry Ranking, 2021 VS 2022 VS 2023
Table 10. Global Key Manufacturers of Siponimod, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Siponimod, Product Type & Application
Table 12. Global Key Manufacturers of Siponimod, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Siponimod by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Siponimod as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Siponimod Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Siponimod Sales by Region (2018-2023) & (K Units)
Table 18. Global Siponimod Sales Market Share by Region (2018-2023)
Table 19. Global Siponimod Sales by Region (2024-2029) & (K Units)
Table 20. Global Siponimod Sales Market Share by Region (2024-2029)
Table 21. Global Siponimod Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global Siponimod Revenue Market Share by Region (2018-2023)
Table 23. Global Siponimod Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Siponimod Revenue Market Share by Region (2024-2029)
Table 25. North America Siponimod Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Siponimod Sales by Country (2018-2023) & (K Units)
Table 27. North America Siponimod Sales by Country (2024-2029) & (K Units)
Table 28. North America Siponimod Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America Siponimod Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Siponimod Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Siponimod Sales by Country (2018-2023) & (K Units)
Table 32. Europe Siponimod Sales by Country (2024-2029) & (K Units)
Table 33. Europe Siponimod Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe Siponimod Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Siponimod Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Siponimod Sales by Region (2018-2023) & (K Units)
Table 37. Asia Pacific Siponimod Sales by Region (2024-2029) & (K Units)
Table 38. Asia Pacific Siponimod Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific Siponimod Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Siponimod Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Siponimod Sales by Country (2018-2023) & (K Units)
Table 42. Latin America Siponimod Sales by Country (2024-2029) & (K Units)
Table 43. Latin America Siponimod Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America Siponimod Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Siponimod Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Siponimod Sales by Country (2018-2023) & (K Units)
Table 47. Middle East & Africa Siponimod Sales by Country (2024-2029) & (K Units)
Table 48. Middle East & Africa Siponimod Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Siponimod Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Siponimod Sales (K Units) by Type (2018-2023)
Table 51. Global Siponimod Sales (K Units) by Type (2024-2029)
Table 52. Global Siponimod Sales Market Share by Type (2018-2023)
Table 53. Global Siponimod Sales Market Share by Type (2024-2029)
Table 54. Global Siponimod Revenue (US$ Million) by Type (2018-2023)
Table 55. Global Siponimod Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Siponimod Revenue Market Share by Type (2018-2023)
Table 57. Global Siponimod Revenue Market Share by Type (2024-2029)
Table 58. Global Siponimod Price (US$/Unit) by Type (2018-2023)
Table 59. Global Siponimod Price (US$/Unit) by Type (2024-2029)
Table 60. Global Siponimod Sales (K Units) by Application (2018-2023)
Table 61. Global Siponimod Sales (K Units) by Application (2024-2029)
Table 62. Global Siponimod Sales Market Share by Application (2018-2023)
Table 63. Global Siponimod Sales Market Share by Application (2024-2029)
Table 64. Global Siponimod Revenue (US$ Million) by Application (2018-2023)
Table 65. Global Siponimod Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Siponimod Revenue Market Share by Application (2018-2023)
Table 67. Global Siponimod Revenue Market Share by Application (2024-2029)
Table 68. Global Siponimod Price (US$/Unit) by Application (2018-2023)
Table 69. Global Siponimod Price (US$/Unit) by Application (2024-2029)
Table 70. Novartis Corporation Information
Table 71. Novartis Description and Business Overview
Table 72. Novartis Siponimod Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 73. Novartis Siponimod Product
Table 74. Novartis Recent Developments/Updates
Table 75. Key Raw Materials Lists
Table 76. Raw Materials Key Suppliers Lists
Table 77. Siponimod Distributors List
Table 78. Siponimod Customers List
Table 79. Siponimod Market Trends
Table 80. Siponimod Market Drivers
Table 81. Siponimod Market Challenges
Table 82. Siponimod Market Restraints
Table 83. Research Programs/Design for This Report
Table 84. Key Data Information from Secondary Sources
Table 85. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Product Picture of Siponimod
Figure 2. Global Siponimod Market Value Comparison by Type (2023-2029) & (US$ Million)
Figure 3. Global Siponimod Market Share by Type in 2022 & 2029
Figure 4. 0.25mg Product Picture
Figure 5. 0.2mg Product Picture
Figure 6. Global Siponimod Market Value Comparison by Application (2023-2029) & (US$ Million)
Figure 7. Global Siponimod Market Share by Application in 2022 & 2029
Figure 8. Retail Pharmacy
Figure 9. Hospital Pharmacy
Figure 10. Other
Figure 11. Global Siponimod Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 12. Global Siponimod Market Size (2018-2029) & (US$ Million)
Figure 13. Global Siponimod Sales (2018-2029) & (K Units)
Figure 14. Global Siponimod Average Price (US$/Unit) & (2018-2029)
Figure 15. Siponimod Report Years Considered
Figure 16. Siponimod Sales Share by Manufacturers in 2022
Figure 17. Global Siponimod Revenue Share by Manufacturers in 2022
Figure 18. The Global 5 and 10 Largest Siponimod Players: Market Share by Revenue in 2022
Figure 19. Siponimod Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 20. Global Siponimod Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 21. North America Siponimod Sales Market Share by Country (2018-2029)
Figure 22. North America Siponimod Revenue Market Share by Country (2018-2029)
Figure 23. United States Siponimod Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 24. Canada Siponimod Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 25. Europe Siponimod Sales Market Share by Country (2018-2029)
Figure 26. Europe Siponimod Revenue Market Share by Country (2018-2029)
Figure 27. Germany Siponimod Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 28. France Siponimod Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 29. U.K. Siponimod Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. Italy Siponimod Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. Russia Siponimod Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. Asia Pacific Siponimod Sales Market Share by Region (2018-2029)
Figure 33. Asia Pacific Siponimod Revenue Market Share by Region (2018-2029)
Figure 34. China Siponimod Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 35. Japan Siponimod Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. South Korea Siponimod Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. India Siponimod Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. Australia Siponimod Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. China Taiwan Siponimod Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. Indonesia Siponimod Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. Thailand Siponimod Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. Malaysia Siponimod Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. Latin America Siponimod Sales Market Share by Country (2018-2029)
Figure 44. Latin America Siponimod Revenue Market Share by Country (2018-2029)
Figure 45. Mexico Siponimod Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. Brazil Siponimod Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Argentina Siponimod Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 48. Middle East & Africa Siponimod Sales Market Share by Country (2018-2029)
Figure 49. Middle East & Africa Siponimod Revenue Market Share by Country (2018-2029)
Figure 50. Turkey Siponimod Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 51. Saudi Arabia Siponimod Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 52. UAE Siponimod Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 53. Global Sales Market Share of Siponimod by Type (2018-2029)
Figure 54. Global Revenue Market Share of Siponimod by Type (2018-2029)
Figure 55. Global Siponimod Price (US$/Unit) by Type (2018-2029)
Figure 56. Global Sales Market Share of Siponimod by Application (2018-2029)
Figure 57. Global Revenue Market Share of Siponimod by Application (2018-2029)
Figure 58. Global Siponimod Price (US$/Unit) by Application (2018-2029)
Figure 59. Siponimod Value Chain
Figure 60. Siponimod Production Process
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Distributors Profiles
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Figure 1. Product Picture of Siponimod
Figure 2. Global Siponimod Market Value Comparison by Type (2023-2029) & (US$ Million)
Figure 3. Global Siponimod Market Share by Type in 2022 & 2029
Figure 4. 0.25mg Product Picture
Figure 5. 0.2mg Product Picture
Figure 6. Global Siponimod Market Value Comparison by Application (2023-2029) & (US$ Million)
Figure 7. Global Siponimod Market Share by Application in 2022 & 2029
Figure 8. Retail Pharmacy
Figure 9. Hospital Pharmacy
Figure 10. Other
Figure 11. Global Siponimod Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 12. Global Siponimod Market Size (2018-2029) & (US$ Million)
Figure 13. Global Siponimod Sales (2018-2029) & (K Units)
Figure 14. Global Siponimod Average Price (US$/Unit) & (2018-2029)
Figure 15. Siponimod Report Years Considered
Figure 16. Siponimod Sales Share by Manufacturers in 2022
Figure 17. Global Siponimod Revenue Share by Manufacturers in 2022
Figure 18. The Global 5 and 10 Largest Siponimod Players: Market Share by Revenue in 2022
Figure 19. Siponimod Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 20. Global Siponimod Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 21. North America Siponimod Sales Market Share by Country (2018-2029)
Figure 22. North America Siponimod Revenue Market Share by Country (2018-2029)
Figure 23. United States Siponimod Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 24. Canada Siponimod Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 25. Europe Siponimod Sales Market Share by Country (2018-2029)
Figure 26. Europe Siponimod Revenue Market Share by Country (2018-2029)
Figure 27. Germany Siponimod Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 28. France Siponimod Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 29. U.K. Siponimod Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. Italy Siponimod Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. Russia Siponimod Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. Asia Pacific Siponimod Sales Market Share by Region (2018-2029)
Figure 33. Asia Pacific Siponimod Revenue Market Share by Region (2018-2029)
Figure 34. China Siponimod Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 35. Japan Siponimod Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. South Korea Siponimod Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. India Siponimod Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. Australia Siponimod Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. China Taiwan Siponimod Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. Indonesia Siponimod Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. Thailand Siponimod Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. Malaysia Siponimod Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. Latin America Siponimod Sales Market Share by Country (2018-2029)
Figure 44. Latin America Siponimod Revenue Market Share by Country (2018-2029)
Figure 45. Mexico Siponimod Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. Brazil Siponimod Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Argentina Siponimod Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 48. Middle East & Africa Siponimod Sales Market Share by Country (2018-2029)
Figure 49. Middle East & Africa Siponimod Revenue Market Share by Country (2018-2029)
Figure 50. Turkey Siponimod Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 51. Saudi Arabia Siponimod Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 52. UAE Siponimod Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 53. Global Sales Market Share of Siponimod by Type (2018-2029)
Figure 54. Global Revenue Market Share of Siponimod by Type (2018-2029)
Figure 55. Global Siponimod Price (US$/Unit) by Type (2018-2029)
Figure 56. Global Sales Market Share of Siponimod by Application (2018-2029)
Figure 57. Global Revenue Market Share of Siponimod by Application (2018-2029)
Figure 58. Global Siponimod Price (US$/Unit) by Application (2018-2029)
Figure 59. Siponimod Value Chain
Figure 60. Siponimod Production Process
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Distributors Profiles
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
